The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Chief Executive and AGM Statement

21 Oct 2014 07:00

RNS Number : 8214U
Ashley House PLC
21 October 2014
 

 

 

21 October 2014

 

Ashley House plc

Change of Chief Executive and AGM Statement

 

 

Ashley House plc ("Ashley House" or the "Company") the health and community care property partner will today hold its Annual General Meeting (AGM) and advises a change in the roles of the Executive Directors.

 

At the AGM Christopher Lyons, Chairman, will make the following statement:

"The activity of the Company is now beginning to escalate and with the pipeline growing, the Board has reviewed the deployment of its senior resources. In order to best deliver the opportunities we are creating, the Board has agreed that Jonathan Holmes should assume the new position of Commercial Director to focus on the generation and commercial delivery of the Company's schemes.

Antony Walters, currently Finance Director will become Chief Executive with immediate effect. Antony successfully led Sapphire Primary Care Developments as Managing Director until its sale to Ashley House in 2009. Antony and Jonathan will continue to run the business with support from the Non-executive directors and the senior team.

Further to my update last month given with the preliminary statements, the Company continues to make progress in the development of the Extra Care schemes. We now have planning approval, or planning applications in process for in excess of 450 new homes which, when they are all built out will amount to around £60m of revenue. We expect these numbers to increase as our growing pipeline of schemes progress through the design process.

We announced in September that we had signed a Memorandum of Understanding with a major UK investment fund manager to provide the funding to secure this delivery and work continues apace on this and other funding streams. Whilst as anticipated the half year of 31 October will show an EBITDA loss, once the funding has been secured, the Board remains confident of the delivery of the full year's results in line with market expectations, and the future looks promising."

 

 

Enquiries:

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

 

WH Ireland Ltd. 0207 220 1666

(Nominated Adviser and broker to Ashley House plc)

Adrian Hadden

Mark Leonard

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFEEADPLFAF
Date   Source Headline
11th Dec 20205:30 pmRNSAshley House
11th Dec 20207:00 amRNSReverse Takeover Update and Administration
26th Aug 20201:27 pmRNSProposed Company Voluntary Arrangement
24th Aug 20207:00 amRNSProposed CVA – second adjournment of meeting
18th Aug 20201:05 pmRNSProposed CVA – adjournment of meeting
30th Jul 202012:25 pmRNSProposed CVA and potential Reverse Takeover
7th May 20205:25 pmRNSSale of Interests in PHL and LIFT
30th Mar 20201:59 pmRNSAdministration of F1 Modular and General Update
6th Mar 20207:30 amRNSSuspension - Ashley House Plc
6th Mar 20207:00 amRNSFinancial Update & Suspension of Trading
2nd Mar 202011:53 amRNSHolding(s) in Company
27th Feb 20207:00 amRNSTrading update & Withdrawal from NEX
31st Jan 20207:00 amRNSTrading Update
30th Jan 20201:45 pmRNSHolding(s) in Company
11th Dec 201911:01 amRNSAppointment of Non-executive director
10th Dec 201911:29 amRNSResult of Annual General Meeting
10th Dec 20197:00 amRNSAnnual General Meeting and Trading update
14th Nov 20197:00 amRNSYear End Change, Trading Update and Interim Report
7th Nov 20195:04 pmRNSDirectors' & PDMRs' Dealings
1st Nov 201910:10 amRNSHolding(s) in Company
30th Oct 20197:00 amRNSHolding(s) in Company
24th Oct 20192:23 pmRNSHolding(s) in Company
23rd Oct 20194:29 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSale of Interest in Morgan Ashley
2nd Sep 20197:00 amRNSTrading Update
6th Aug 20197:00 amRNSDirectorate Change
5th Aug 20197:00 amRNSDirector/PDMR Shareholding
1st Aug 20192:05 pmRNSSecond Price Monitoring Extn
1st Aug 20192:00 pmRNSPrice Monitoring Extension
1st Aug 20197:00 amRNSTrading Update
5th Jul 20197:00 amRNSTrading Update
28th Jun 201911:51 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSTrading Update
9th May 201910:19 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSSchemes Update
3rd May 20191:21 pmRNSDirector/PDMR Shareholding
18th Feb 201912:56 pmRNSHolding(s) in Company
15th Feb 20192:53 pmRNSHolding(s) in Company
15th Feb 20192:50 pmRNSHolding(s) in Company
14th Feb 20194:41 pmRNSSecond Price Monitoring Extn
14th Feb 20194:35 pmRNSPrice Monitoring Extension
1st Feb 20191:38 pmRNSDirectors' & PDMRs' Dealings
31st Jan 20197:00 amRNSInterim Report
28th Jan 20199:40 amRNSAdditional Directorships - Andrew Willetts
16th Jan 201912:50 pmRNSChange of Accounting Year End
1st Nov 20187:00 amRNSDirectors' & PDMRs' Dealings
12th Sep 20181:08 pmRNSResult of AGM
16th Aug 20187:00 amRNSPreliminary Results
9th Aug 20187:00 amRNSJohn Moy
1st Aug 201811:34 amRNSDirectors' & PDMRs' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.